# Phase 0: Final Gatekeeper Audit Report

**Target Journal:** Springer Nature, *Data Mining and Knowledge Discovery* (DAMI / DMKD)  
**Repository:** `https://github.com/AkashKundu114/icc-clustering`  
**Audit Persona:** Agent A9 — Final Gatekeeper & Independent Quality Officer  
**Date:** November 1, 2026  
**Dedicated Revision Branch:** `research/dami-revision`  

---

## 1. Executive Gatekeeper Verdict

The Gatekeeper has audited the entire baseline state, Git forensics, claims ledger, algorithmic implementations, independent statistical recalculations, literature taxonomy, and blind reviewer assessment.

### Gate Evaluation Matrix:
- **Gate G0 (Baseline Verified):** **APPROVED**. Code, benchmarks, statistical calculations, and git provenance verified.
- **Gate G1 (Protocol Approved):** **PENDING HUMAN AUTHORIZATION**. Complete hypothesis testing and analysis plan formulated; awaits human review before freeze and tag.
- **Gate G2 (Experiments Complete):** **BLOCKED ON G1**. No confirmatory experiments launched prior to human protocol approval.
- **Gate G3 (Manuscript Consistent):** **PROVISIONAL**. Current manuscript is internally consistent with Pass F results, but requires prominent inclusion of cohort medians and calibration of Proposition 2.
- **Gate G4 (Independent Review):** **APPROVED**. Independent reproducibility audit and blind peer review simulation completed.
- **Gate G5 (Submission Readiness):** **PENDING EXPANSION & EXPERIMENT COMPLETION**.

---

## 2. Gatekeeper Finding Ledger & Action Matrix

### Finding GK-01: Two-Cohort Concentration of BGSS Gain
- **Severity:** **MAJOR**
- **Evidence:** Re-computation of Table 12 reveals that the $+0.169$ mean ARI improvement of Full ICC-v2 over matched random gating is driven by Leukemia ($\text{ARI}=0.5998$) and SRBCT ($\text{ARI}=0.5456$). The remaining 4 cohorts have mean $\text{ARI} = 0.0388$, and the median across all 6 cohorts is $0.061$.
- **File Paths:** `paper/main.tex`, `results/passF/ablation_stats_passF.json`, `research_audit/dami_revision/STATISTICAL_AUDIT.md`
- **Required Gate Action:** The manuscript Abstract, Section 1, and Section 6 must explicitly report the cohort median ($0.061$) alongside the mean ($0.217$) and detail the two-cohort concentration. General claims of "uniform biomedical superiority" must be strictly avoided.

---

### Finding GK-02: Proposition 2 Theoretical Calibration
- **Severity:** **MAJOR**
- **Evidence:** Table 13 Knockout 4 demonstrates that certified core anchors yield an ARI difference of $\Delta = +0.0188$ ($p = 0.8438$) compared to uniform random landmark anchors.
- **File Paths:** `paper/main.tex`, `research_audit/dami_revision/METHOD_AUDIT.md`
- **Required Gate Action:** The text discussing Proposition 2 must explicitly state that while sample determinacy bounds can be formally derived, certified core anchors are an empirical null ($\Delta \approx +0.019, p = 0.84$), and uniform random landmark sampling provides an equivalent bipartite representation.

---

### Finding GK-03: Multiplicity Correction on Small Inferential Sample ($N=6$)
- **Severity:** **MAJOR**
- **Evidence:** The uncorrected Wilcoxon signed-rank test on $n=6$ paired cohorts yields $W = 20.0, p = 0.0312$. Under Holm-Bonferroni correction across the 8-comparison family, $p_{\text{adj}} = 0.2496$.
- **File Paths:** `paper/main.tex`, `research_audit/dami_revision/STATISTICAL_AUDIT.md`
- **Required Gate Action:** Report both uncorrected and family-wise Holm-adjusted $p$-values in all summary tables and text. Explicitly acknowledge that inferences on the original 6 cohorts are exploratory.

---

### Finding GK-04: Baseline Nomenclature & FastMVC Attribution
- **Severity:** **MINOR / REMEDIATED**
- **Evidence:** The baseline `FastMVC` was an internal random-subspace bipartite proxy.
- **File Paths:** `src/icc/baselines/anchor.py`, `paper/main.tex`, `paper/references.bib`
- **Required Gate Action:** Maintain `FastMVC-Surrogate` across all manuscript tables and references. Verified present in current working branch.

---

### Finding GK-05: Post-Hoc Status of Rule (i') Non-Degeneracy Condition
- **Severity:** **MINOR / REMEDIATED**
- **Evidence:** Rule (i') was added post-hoc to exclude trivial 1-cluster collapse partitions.
- **File Paths:** `paper/main.tex`, `scripts/make_stability_outputs.py`
- **Required Gate Action:** Explicitly label Rule (i') as a post-hoc diagnostic criterion in text, and report both unconditional and conditional discordance distributions.

---

## 3. Mandatory Gate G1 Submission Conditions

Before the lead agent or research team creates the Git tag `prereg-dami-v1` or launches confirmatory experiment suites (E1–E8), the human investigator must explicitly review and approve:
1. The classification of the original 6 biomedical cohorts as **EXPLORATORY**.
2. The cohort expansion eligibility criteria and catalog in `research_audit/cohort_discovery/`.
3. The Holm-Bonferroni multiplicity control plan across the 8-method baseline family.
4. The prominent reporting of the cohort-level median ARI ($0.061$) alongside the mean ($0.217$).
5. The calibration of Proposition 2 as an empirical null based on Table 13 Knockout 4.
